Work

Romidepsin (FK228), a histone deacetylase inhibitor: Final results of a phase II study in metastatic hormone refractory prostate cancer (HRPC)

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.15507

Authors: C. Parker, R. Molife, V. Karavasilis, A. Reid, S. G. Patterson, C. Riggs, C. Higano, W. M. Stadler, W. McCulloch, J. S. de Bono

Institutions: Seattle Cancer Care Alliance, Moffitt Cancer Center, University of Florida, University of Chicago, Royal Marsden Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597941047

Cites:

Cited by: 17

Related to: 10